The sleep drug market is about to get a whole lot bigger. “The $2.5 billion U.S. insomnia market is expected to get a whole lot bigger starting in the second half of next year . . .
. . . A massive ad campaign – one analysts compare in magnitude to those for Viagra and Lipitor – is expected to follow six months after the initial rollout of Indiplon.”





![Insulin resistance is a survival mechanism, not a broken system [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-1-190x100.jpg)



![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-4-190x100.jpg)





